A high throughput method to study the physiology of E2:ERα signaling in breast cancer cells. Issue 5 (24th November 2017)

• Record Type: Journal Article
• Authors: Leone, Stefano; Busonero, Claudia; Acconcia, Filippo
• Is Part Of: Journal of cellular physiology. Volume 233:Issue 5(2018:May)
• Page Start: 3713
• Page End: 3722
• Publication Date: 2017-11-24
• Subjects: 4OH‐tamoxifen -- breast cancer -- estrogen receptor -- drug screening -- methotrexate; Physiology -- Periodicals; Cell physiology -- Periodicals; 571.6
• DOI: 10.1002/jcp.26251
• Languages: English
• ISSNs: 0021-9541

Abstract

Abstract : 17β‐estradiol (E2) regulates diverse physiological effects including cell proliferation through the estrogen receptor α (ERα), which as a transcription factor drives gene transcription and as an extra‐nuclear localized receptor triggers the membrane‐dependent activation of diverse kinase cascades. E2 also modifies ERα intracellular levels via diverse intracellular mechanisms. In this way, the E2‐acivated ERα integrates signaling cascades with the modulation of receptor intracellular concentration and with the induction of DNA synthesis and ultimately drives cell proliferation. In turn, E2 signaling deregulation can cause many diseases including breast cancer (BC). Recently, we performed a Western blotting (WB)‐based screen to identify novel pathways affecting ERα intracellular levels and BC cell proliferation. However, because WB lacks high throughput potential, a high‐content method to detect all aspects of E2:ERα signaling (nuclear and extra‐nuclear receptor activity, ERα levels, E2‐induced DNA synthesis) is desirable. Here, we set up a rapid way to measure E2:ERα signaling in 96‐well plate format. To demonstrate its robustness, we also challenged 4OH‐tamoxifen resistant (Tam‐Res) BC cells with a library of anti‐cancer drugs and identified methotrexate (MTX) as a molecule inducing ERα degradation and preventing BC cell proliferation. Overall, our research provides a high‐content technique to study the physiology of E2:ERα signaling in cells and further suggests a possible anti‐ERα and anti‐proliferative use for MTX in Tam‐Res BCs. Abstract : We identified a high throughput method to study various aspects of the physiology of E2:ERα signaling in a contemporary manner. We identified methotrexate as a drug inducing ERα degradation and preventing breast cancer cell proliferation.